Switch to:
More From Other Websites
Drugmaker Valeant completes $11 billion purchase of Salix Apr 01 2015
Valeant closes $11B deal for Raleigh's Salix Pharmaceuticals Apr 01 2015
BioDelivery Slumps, Diabetic Pain Gel Fails Phase III Study - Analyst Blog Mar 31 2015
Can Boston Scientific Keep Its Turnaround Gains Going? Mar 30 2015
Hyperion Could Be Next Pharma Target With Orphan Drugs: Real M&A Mar 28 2015
Point72 Reduces Its Stake in Valeant Pharmaceuticals Mar 27 2015
Two Future Leaders of Specialty Pharma Mar 23 2015
Actavis' Wide-Moat Transformation Offers Shareholder Rewards Mar 23 2015
[$$] Proceedings: News Digest Mar 22 2015
Dovish Fed stance lifts US stocks near records Mar 20 2015
Salix execs – including two that resigned – to receive $78M in golden parachutes Mar 19 2015
Valeant (VRX) Prices Shares to Finance Salix Acquisition - Analyst Blog Mar 18 2015
The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, Salix Pharmaceuticals,... Mar 18 2015
Endo Finance Co. -- Moody's confirms Endo's Ba3 ratings; outlook stable Mar 17 2015
Valeant (VRX) Raises Salix Offer, Endo Withdraws Proposal - Analyst Blog Mar 17 2015
Valeant Bonds Trade Higher, Despite Skepticism Mar 17 2015
Valeant Bumps Its Offer to $173 to Seal the Salix Deal Mar 17 2015
For health-care stocks, buy what executives are buying Mar 17 2015
PRESS DIGEST - Wall Street Journal - March 17 Mar 17 2015
Valeant Wins Battle for Salix Pharmaceuticals Mar 16 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK